Adaptive Biotechnologies
ADPT
ADPT
268 hedge funds and large institutions have $2.18B invested in Adaptive Biotechnologies in 2025 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 91 increasing their positions, 81 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 241 → 268 (+27)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.02% less ownership
Funds ownership: 97.54% → 95.52% (-2%)
Holders
268
Holding in Top 10
2
Calls
$821K
Puts
$534K
Top Buyers
| 1 | +$40.9M | |
| 2 | +$30.9M | |
| 3 | +$23.1M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$21.6M |
| 5 |
Jennison Associates
New York
|
+$18.2M |
Top Sellers
| 1 | -$72.9M | |
| 2 | -$46.8M | |
| 3 | -$15.8M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$12.7M |
| 5 |
JP Morgan Chase
New York
|
-$12M |
